Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies
- 31 August 2000
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 26 (5) , 463-470
- https://doi.org/10.1038/sj.bmt.1702561
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Relationship of plasma pharmacokinetics of high-dose oral busulfan to the outcome of allogeneic bone marrow transplantation in children with thalassemiaBone Marrow Transplantation, 1997
- High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patientsBone Marrow Transplantation, 1997
- ALLOGENEIC TRANSPLANTATION FOR ADVANCED LEUKEMIATransplantation, 1996
- Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantationCancer Chemotherapy and Pharmacology, 1995
- Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantationCancer Chemotherapy and Pharmacology, 1989
- Regimen-related toxicity in patients undergoing bone marrow transplantation.Journal of Clinical Oncology, 1988
- Measurement of busulfan in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATIONTransplantation, 1987
- A program package for simulation and parameter estimation in pharmacokinetic systemsComputer Programs in Biomedicine, 1979
- Geometric method for measuring body surface area: A height-weight formula validated in infants, children, and adultsThe Journal of Pediatrics, 1978